WallStreetZenWallStreetZen

NASDAQ: ACLX
Arcellx Inc Stock Ownership - Who owns Arcellx?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Arcellx Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kavita PatelDirector2025-06-101,500$6.66
$9.99kBuy
Kavita PatelDirector2025-06-101,500$67.36
$101.04kSell
Michelle GilsonCHIEF FINANCIAL OFFICER2025-05-278,449$64.38
$543.91kSell
Michelle GilsonCHIEF FINANCIAL OFFICER2025-05-273,786$63.62
$240.87kSell
Kavita PatelDirector2025-05-201,500$6.66
$9.99kBuy
Kavita PatelDirector2025-05-201,500$58.43
$87.65kSell
Kavita PatelDirector2025-04-291,500$64.20
$96.30kSell
Kavita PatelDirector2025-04-291,500$6.66
$9.99kBuy
Kavita PatelDirector2025-04-081,500$57.50
$86.25kSell
Kavita PatelDirector2025-04-081,500$6.66
$9.99kBuy

1 of 11

ACLX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACLX insiders and whales buy or sell their stock.

ACLX Shareholders

What type of owners hold Arcellx Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gilead Sciences Inc12.20%6,720,803$479.06MInsider
Gilead Sciences Inc12.20%6,720,803$479.06MInstitution
Sr One Capital Management LLC11.83%6,520,370$464.77MInsider
Jill Carroll11.51%6,340,738$451.97MInsider
Fmr LLC10.84%5,972,151$425.69MInstitution
Scott D. Sandell8.62%4,748,116$338.45MInsider
Peter W. Sonsini8.61%4,746,083$338.30MInsider
Mohamad Makhzoumi8.61%4,745,545$338.26MInsider
Nea Partners 15 LP8.61%4,745,262$338.24MInsider
New Enterprise Associates 15 LP8.61%4,745,262$338.24MInsider

1 of 3

ACLX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACLX50.50%49.50%Net SellingNet Selling
AKRO74.92%25.08%Net BuyingNet Selling
PTCT84.82%15.18%Net SellingNet Selling
ZLAB3.93%1.76%Net SellingNet Selling
TLX0.14%0.00%
View Top Biotech Stocks

Arcellx Stock Ownership FAQ

Who owns Arcellx?

Arcellx (NASDAQ: ACLX) is owned by 111.37% institutional shareholders, 109.18% Arcellx insiders, and 0.00% retail investors. Gilead Sciences Inc is the largest individual Arcellx shareholder, owning 6.72M shares representing 12.20% of the company. Gilead Sciences Inc's Arcellx shares are currently valued at $479.06M.

If you're new to stock investing, here's how to buy Arcellx stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.